Results 291 to 300 of about 1,982,916 (349)
Some of the next articles are maybe not open access.
Annals of Plastic Surgery, 2023
Abstract Salivary ductal carcinoma is an extremely rare tumor located in the parotid gland. This case details a salivary ductal carcinoma within the parotid gland of a 59-year-old man and its management.
Si-Qi, Mu, Xi, Zhang, Jie, Chen
openaire +2 more sources
Abstract Salivary ductal carcinoma is an extremely rare tumor located in the parotid gland. This case details a salivary ductal carcinoma within the parotid gland of a 59-year-old man and its management.
Si-Qi, Mu, Xi, Zhang, Jie, Chen
openaire +2 more sources
Clinical Breast Cancer, 2017
Micro‐Abstract This study illustrates that tumor characteristics can be captured by medical images at the genetic and cellular levels. The data from 215 patients with breast invasive ductal carcinoma were analyzed.
Yi Guo +6 more
semanticscholar +1 more source
Micro‐Abstract This study illustrates that tumor characteristics can be captured by medical images at the genetic and cellular levels. The data from 215 patients with breast invasive ductal carcinoma were analyzed.
Yi Guo +6 more
semanticscholar +1 more source
Surgical Clinics of North America, 2018
Ductal carcinoma in situ has been stable in incidence for a decade and has an excellent prognosis. Breast conservation therapy is safe and effective for most patients. Adjuvant whole breast radiation therapy is recommended to reduce the risk of local recurrence.
FangMeng, Fu +2 more
openaire +2 more sources
Ductal carcinoma in situ has been stable in incidence for a decade and has an excellent prognosis. Breast conservation therapy is safe and effective for most patients. Adjuvant whole breast radiation therapy is recommended to reduce the risk of local recurrence.
FangMeng, Fu +2 more
openaire +2 more sources
Surgical Clinics of North America, 2003
DCIS is a heterogeneous disease whose natural history is poorly defined. Screening mammography has increased the detection rate of DCIS, but we remain unable to identify cases of DCIS that will not progress to invasive carcinoma during an individual's lifetime.
Faina, Nakhlis, Monica, Morrow
openaire +2 more sources
DCIS is a heterogeneous disease whose natural history is poorly defined. Screening mammography has increased the detection rate of DCIS, but we remain unable to identify cases of DCIS that will not progress to invasive carcinoma during an individual's lifetime.
Faina, Nakhlis, Monica, Morrow
openaire +2 more sources
Surgical Clinics of North America, 2013
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +2 more sources
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +2 more sources
American Journal of Surgical Pathology, 2010
Pancreatic acinar cell carcinomas (ACCs) are clinically and pathologically distinct from pancreatic ductal adenocarcinomas (PDAs). Whereas endocrine differentiation has been well shown in ACCs, significant ductal components are rare. This paper reviews the clinicopathologic features of a series of ACCs with prominent ductal differentiation.Cases of ...
Edward B, Stelow +4 more
openaire +2 more sources
Pancreatic acinar cell carcinomas (ACCs) are clinically and pathologically distinct from pancreatic ductal adenocarcinomas (PDAs). Whereas endocrine differentiation has been well shown in ACCs, significant ductal components are rare. This paper reviews the clinicopathologic features of a series of ACCs with prominent ductal differentiation.Cases of ...
Edward B, Stelow +4 more
openaire +2 more sources
Breast Disease, 2001
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +2 more sources
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +2 more sources
1996
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire +2 more sources
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire +2 more sources
Cancer Cell, 2005
To define the genetic requirements for pancreatic ductal adenocarcinoma (PDA), we have targeted concomitant endogenous expression of Trp53(R172H) and Kras(G12D) to the mouse pancreas, revealing the cooperative development of invasive and widely ...
S. Hingorani +8 more
semanticscholar +1 more source
To define the genetic requirements for pancreatic ductal adenocarcinoma (PDA), we have targeted concomitant endogenous expression of Trp53(R172H) and Kras(G12D) to the mouse pancreas, revealing the cooperative development of invasive and widely ...
S. Hingorani +8 more
semanticscholar +1 more source
Treatment of low-risk ductal carcinoma in situ: is nothing better than something?
The Lancet Oncology, 2016J. Benson, I. Jatoi, M. Toi
semanticscholar +1 more source